The latest announcement is out from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ).
ResMed Inc has filed a Form 144 notice for the proposed sale of securities, indicating that an officer of the company, Kaushik Ghoshal, plans to sell 9,113 shares of common stock with an aggregate market value of approximately $2,145,408.15. The sale is scheduled for March 3, 2025, on the NYSE, and the shares were acquired through options granted in 2019 and 2020. This transaction reflects a routine financial move by company insiders and is not expected to impact the company’s operations or market positioning significantly.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc is a company operating in the healthcare industry, primarily focused on providing medical equipment and services related to sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. The company is known for its innovative solutions and devices that improve the quality of life for patients with respiratory disorders.
YTD Price Performance: 1.17%
Average Trading Volume: 1,026,255
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$55.08B
See more insights into RMD stock on TipRanks’ Stock Analysis page.